SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001860782-24-000095
Filing Date
2024-08-07
Accepted
2024-08-07 07:30:28
Documents
14
Period of Report
2024-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tvst-20240807.htm   iXBRL 8-K 27709
2 EX-99.1 tsvt-872024pr.htm EX-99.1 110309
  Complete submission text file 0001860782-24-000095.txt   284168

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvst-20240807.xsd EX-101.SCH 2010
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvst-20240807_lab.xml EX-101.LAB 22530
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvst-20240807_pre.xml EX-101.PRE 13144
16 EXTRACTED XBRL INSTANCE DOCUMENT tvst-20240807_htm.xml XML 2808
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

IRS No.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40791 | Film No.: 241181452
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)